Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J4MY
|
||||
| Former ID |
DCL000333
|
||||
| Drug Name |
Tasidotin hydrochloride
|
||||
| Synonyms |
Tasidotin HCl; BSF 223651; ILX 651; LU 223651; Tasidotin hydrochloride (USAN)
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [528421] | ||
| Company |
Genzyme
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C32H59ClN6O5
|
||||
| Canonical SMILES |
CC(C)C(C(=O)N(C)C(C(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC<br />(C)(C)C)NC(=O)C(C(C)C)N(C)C.Cl
|
||||
| InChI |
1S/C32H58N6O5.ClH/c1-19(2)24(33-28(40)25(20(3)4)35(10)11)30(42)36(12)26(21(5)6)31(43)38-18-14-16-23(38)29(41)37-17-13-15-22(37)27(39)34-32(7,8)9;/h19-26H,13-18H2,1-12H3,(H,33,40)(H,34,39);1H/t22-,23-,24-,25-,26-;/m0./s1
|
||||
| InChIKey |
OOKIODJYZSVHDO-QMYFOHRPSA-N
|
||||
| CAS Number |
CAS 623174-20-9
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Tubulin beta | Target Info | Binder | [536891] | |
| PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
| Huntington disease | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.